Related Experiment Video
Updated: Aug 17, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?
1Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond.
Abstract:
Fixed-dose combination antihypertensive therapy has been available for over 25 years. During that time, considerable progress has been made in the development of physiologically appropriate combinations. The inherent advantage of fixed-dose combination therapy resides in its improving compliance because fewer pills are required. Alternatively, fixed-dose combination therapy limits dosage flexibility and dose titration of a single component of the combination to complement ongoing treatment of a concomitant non-hypertensive illness. The most frequently employed fixed-dose combinations include some form of a thiazide diuretic together with either a potassium-sparing diuretic, beta-blocker or an angiotensin converting enzyme inhibitor. Newer combinations using a calcium channel blocker and beta-blocker, or a calcium channel blocker and an angiotensin converting enzyme inhibitor are either in development or soon to be available. Such developments, if combined with appropriate cost reductions will ultimately increase the popularity of these combination drug administration strategies.
Related Concept Videos
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
